Balyasny Asset Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,238
| Closed | -$90.6K | – | 2012 |
|
|
2024
Q2 | $90.6K | Sell |
16,238
-29,529
| -65% | -$165K | ﹤0.01% | 1770 |
|
|
2024
Q1 | $307K | Buy |
45,767
+16,840
| +58% | +$113K | ﹤0.01% | 1650 |
|
|
2023
Q4 | $264K | Buy |
28,927
+15,267
| +112% | +$139K | ﹤0.01% | 1662 |
|
|
2023
Q3 | $75.4K | Sell |
13,660
-68,304
| -83% | -$377K | ﹤0.01% | 1660 |
|
|
2023
Q2 | $700K | Sell |
81,964
-40,055
| -33% | -$342K | ﹤0.01% | 1366 |
|
|
2023
Q1 | $1.12M | Sell |
122,019
-994
| -0.8% | -$9.14K | ﹤0.01% | 1306 |
|
|
2022
Q4 | $1.26M | Buy |
+123,013
| New | +$1.26M | ﹤0.01% | 1198 |
|